Previous reports have suggested that PDK1 plays an important role in cancer (Wang and Sun, 2018), and it is often modified by microRNAs or used as a drug target (Zhou et al., 2017; Wang and Sun, 2018; Wang et al., 2019). This evidence concerns the gene PDK1 and cancer.